Recruiting now—Ages 1 Year and up
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
Sponsor: N.N. Petrov National Medical Research Center of Oncology · NCT05539677 on ClinicalTrials.gov ↗
Conditions studied
Malignant Solid TumorsPrimary Brain TumorMelanomaSoft Tissue SarcomaColorectal CancerKidney CancerProstate Cancer
Where it's running1 site
1 international site
- Recruiting now
N.N. Petrov NMRC of Oncology, Oncoimmunology dep.
Saint Petersburg, Russia 197758
- Aleksei Novik, MD, PhD(contact)+78124399505[email protected]
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Signed inform consent * Histolgically verified solid tumour * Receiving systemic therapy for neoplasm * Has archival tumour tissue * Provide biosamples with living tumour tissue or blood samples for immunologic assessment Exclusion Criteria: * Concurrent Lymphoprolipherative disorder * Patients after stem cell or bone marrow thansplantation * Incomplete informaton on previous cancer history or medical history * Patients with known primary immunodeficiency * Patients receiving immunosupressive therapy for concurrent illness * Pregnant patients
Updated 2024-05-06 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.